使用二碳酸治疗COVID-19的化:系统性审查和元分析
Arman Shafiee1, Kyana Jafarabady1, Hassan Moltazemi1
1Student Research Committee, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
Journal of evidence-based integrative medicine
|June 3, 2024
概括
使用碳酸的化可能通过减少死亡率和加快恢复来改善COVID-19的结果. 需要进一步的研究来证实这些发现对COVID-19患者.
科学领域:
- 医学研究 医学研究
- 基于证据的医学基于证据的医学.
- 传染性疾病 传染性疾病
背景情况:
- COVID-19 给全球健康带来了重大挑战.
- 研究新的治疗策略对于患者管理至关重要.
- 化正在被探索为一种潜在的辅助治疗COVID-19.
研究的目的:
- 系统地审查和分析当前关于化在COVID-19患者疗效的证据.
- 为了确定化对关键COVID-19结果的影响.
- 评估化作为辅助疗法的安全性和有效性.
主要方法:
- 在主要数据库 (MEDLINE,科学网,科克兰图书馆,Clinicaltrials.gov) 进行全面的文献搜索,截至2023年4月.
- 按照PRISMA 2020指南进行的系统审查和元分析.
- 包括评估COVID-19患者化功效的研究.
主要成果:
- 分析显示,化的死亡率显著降低 (RR 0.73).
- 在康复率 (RR 2.13) 和康复持续时间 (SMD 0.76) 中观察到显著改善.
- 医院住院时间缩短 (SMD -0.66),尽管证据确定性很低.
结论:
- 化,特别是用二碳酸,显示出作为COVID-19有效和安全的辅助治疗的潜力.
- 有证据表明,在降低死亡率,更快的恢复和更短的住院时间方面有好处.
- 进一步高质量的随机对照试验是必要的,以巩固这些发现.
相关概念视频
01:28Pneumonia IV: Management
322
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
322
01:29Acute Respiratory Failure-V
132
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
132